脂肪乳治疗急性有机磷中毒:一项开放标签随机试验
这项在印度昌迪加尔PGIMER开展的由研究者发起的平行组开放标签随机对照试验,纳入45例13岁以上急性有机磷中毒患者,比较标准治疗基础上加用20%脂肪乳(ILE,先100 ml负荷后100 ml/6 h输注,n=23)与生理盐水(n=22)。主要疗效终点为胆碱能危象所需阿托品剂量(总量及最初24小时),两组相似:最初24小时中位剂量ILE组124.0 mg vs 对照组141.8 mg(p=0.916),完全缓解时150.8 mg vs 175.0 mg(p=0.935)。血流动力学指标(收缩压、舒张压、平均动脉压、脉率)在24、48、72小时、住院时间及机械通气时长均不受ILE影响;病死率两组无统计学差异(ILE组1例 vs 对照组3例,p=0.346)。ILE组未见过度发热、呼吸困难、血清淀粉酶升高或胰腺炎。结论认为ILE对急性有机磷中毒无明显获益,但延长剂量在该适应症看来安全。
要点
- 急性有机磷中毒患者标准治疗加用20%脂肪乳(首剂100 ml负荷后100 ml/6 h输注)与生理盐水相比,最初24小时阿托品中位剂量无差异(124.0 mg vs 141.8 mg,p=0.916)。
- 完全缓解时阿托品中位总剂量两组亦无差异(ILE组150.8 mg vs 对照组175.0 mg,p=0.935)。
- 血流动力学指标(收缩压、舒张压、平均动脉压、脉率)在24、48、72小时、住院时间及机械通气时长均不受ILE影响。
- 病死率两组无统计学差异(ILE组1例 vs 对照组3例,p=0.346)。
- ILE组未见过度发热、呼吸困难、血清淀粉酶升高或胰腺炎,延长剂量方案看来安全。
适用人群与场景
- 年龄大于13岁的急性有机磷中毒患者(印度昌迪加尔PGIMER,2019年1月至2020年6月)。
处置流程与药物剂量
- 干预组在标准治疗基础上给予20%脂肪乳:初始负荷剂量100 ml,随后6小时内输注100 ml。
- 对照组在标准治疗基础上给予生理盐水。
研究设计与关键结果
- 研究类型:由研究者发起的平行组开放标签随机对照试验;总样本45例,ILE组23例,对照组22例;两组基线变量可比。
- 主要终点:最初24小时阿托品中位剂量ILE组124.0 mg vs 对照组141.8 mg(p=0.916);完全缓解时中位剂量ILE组150.8 mg vs 对照组175.0 mg(p=0.935)。
- 次要终点:24、48、72小时血流动力学变量(收缩压、舒张压、平均动脉压、脉率)、住院时间及机械通气时长均不受ILE影响。
- 病死率:ILE组1例 vs 对照组3例(p=0.346),无统计学差异。
- 不良事件:ILE组未见过度发热、呼吸困难、血清淀粉酶升高或胰腺炎。
证据类型、等级与局限
- 证据类型:随机对照试验(开放标签)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ILE对急性有机磷中毒无明显获益,但延长剂量在该适应症看来安全。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Many organophosphate (OP) pesticides are lipid-soluble; therefore, intravenous lipid emulsion (ILE) has been evaluated as a possible treatment for acute poisoning. A single bolus dose of 100 ml of 20% ILE was found safe in a pilot observational study. This randomized trial aimed to assess the effectiveness and safety of an extended dose of ILE in acute OP poisoning.
METHODS: This was an investigator-initiated, parallel-group, open-label, randomized controlled trial conducted at PGIMER, Chandigarh (India), from January 2019 to June 2020, in patients aged above 13 years with acute OP poisoning. The primary efficacy outcome was to study the change in atropine dose requirement (total and over the first 24 h) for cholinergic crisis after giving an initial bolus dose of 100 ml of 20% ILE followed by an infusion of 100 ml of 20% ILE over 6 h in addition to the standard care. The secondary efficacy outcomes were to detect the effects on hemodynamic variables, length of hospital stay, and duration of mechanical ventilation required. The incidence of adverse events was evaluated.
RESULTS: A total of 45 patients were assigned to receive either ILE (intervention group, n = 23) or normal saline (control group, n = 22) in addition to standard treatment. Baseline variables in both groups were comparable. The median dose of atropine (in mg) in the first 24 h and at complete resolution in the ILE group were similar to the control group (124.0 versus 141.8, p-value 0.916; and 150.8 versus 175.0, p-value 0.935). Hemodynamic variables (systolic and diastolic blood pressures, mean arterial pressure, and pulse rate) over 24, 48, and 72 h of treatment, length of hospital stay, and duration of mechanical ventilation were also unaffected by ILE. Case fatality was 4 and not statistically different between intervention and control groups (1 versus 3, p-value 0.346). There was no excessive fever, dyspnea, elevation of serum amylase, or pancreatitis from ILE.
CONCLUSION: ILE has no apparent benefit in acute OP poisoning. However, an extended dose appears safe for the indication.
参考来源
- Pannu AK, Garg S, Bhalla A, et al. Lipid emulsion for the treatment of acute organophosphate poisoning: an Open-Label randomized trial. Clin Toxicol (Phila). 2021. PMID: 34928182. doi:10.1080/15563650.2021.2013496
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。